| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +500K | 16.7% | $37.58 | +$18.8M |
| Sells | 16 | -2.49M | 83.3% | $40.09 | -$99.9M |
| Net | -15 | -1.99M | -66.6% | -$81.1M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 10%+ Owner | $385M | -$82.4M | -17.6% | Dec 10, 2024 |
| Srinivas Akkaraju | Director | $218M | +$18.8M | +9.44% | Oct 3, 2025 |
| Samsara BioCapital GP, LLC | 10%+ Owner | $108M | Oct 16, 2023 | ||
| Siren, L.L.C. | 10%+ Owner | $101M | Jul 25, 2024 | ||
| Kristina Burow | Director | $74.3M | -$161K | -0.22% | May 29, 2025 |
| David Hallal | Chief Executive Officer, Director | $67.2M | Oct 8, 2025 | ||
| Vikas Sinha | Chief Financial Officer | $19.3M | May 2, 2025 | ||
| Keith Woods | Chief Operating Officer | $19.3M | May 2, 2025 | ||
| Akshay Vaishnaw | President of R&D, Director | $18.5M | -$201K | -1.07% | May 29, 2025 |
| Jay T. Backstrom | CHIEF EXECUTIVE OFFICER, Director | $16.1M | -$1.66M | -9.38% | Mar 10, 2025 |
| Nagesh K. Mahanthappa | Interim CEO and President | $7.65M | Jun 16, 2022 | ||
| Junlin Ho | General Counsel | $7.12M | -$849K | -10.7% | Jun 16, 2025 |
| Caryn Parlavecchio | Chro | $4.85M | -$745K | -13.3% | Aug 18, 2025 |
| Yung H. Chyung | Chief Medical Officer | $4.12M | Feb 14, 2022 | ||
| Edward H. Myles | Coo & Cfo | $3.88M | -$5.91M | -60.4% | Mar 10, 2025 |
| Jing L. Marantz | Chief Medical Officer | $3.83M | -$566K | -12.9% | Mar 10, 2025 |
| Mo Qatanani | Chief Scientific Officer | $3.34M | -$4.2M | -55.7% | Sep 22, 2025 |
| Erin Moore | Interim PFO and PAO | $2.74M | -$449K | -14.1% | Mar 24, 2025 |
| Tracey Sacco | Chief Commercial Officer | $2.4M | -$551K | -18.7% | Apr 25, 2025 |
| Gregory John Carven | Chief Scientific Officer | $2.04M | Jun 16, 2022 | ||
| Michael Gilman | Director | $1.65M | -$100K | -5.74% | May 29, 2025 |
| Katie Peng | Director | $1.13M | -$164K | -12.7% | Sep 16, 2025 |
| Jeffrey S. Flier | Director | $756K | -$1.65M | -68.6% | Jul 16, 2025 |
| Amir Nashat | Director | $608K | May 9, 2024 | ||
| Joshua Reed | Director | $473K | -$160K | -25.3% | May 29, 2025 |
| Richard Brudnick | Director | $452K | -$181K | -28.6% | May 29, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|